Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kapyon Ventures is a private San Diego-based venture and incubation firm that develops and finances technology spinouts from global research institutes. Its activity appears to center on company creation and early-stage investment rather than operating as a drug developer, with historical focus areas including agricultural biotechnology, industrial biotechnology, and cleantech. Publicly available sources associate Kapyon Ventures with portfolio companies such as ZeaKal, Algenetix, and PhytaGro. The firm therefore sits adjacent to life sciences and biotechnology, but it does not appear to maintain a conventional therapeutic pipeline, clinical-stage assets, or marketed healthcare products of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kapyon Ventures.